Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness. (Q55056589)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness. |
scientific article |
Statements
1 reference
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness. (English)
1 reference
Anuraag R Kansal
1 reference
Michael Sharma
1 reference
Carole Bradley-Kennedy
1 reference
Andreas Clemens
1 reference
Brigitta U Monz
1 reference
Siyang Peng
1 reference
Neil Roskell
1 reference
Sonja V Sorensen
1 reference
17 August 2012
1 reference
108
1 reference
4
1 reference
672-682
1 reference
Identifiers
1 reference